Cargando…

Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol

Background: Several studies have demonstrated that using a higher dose of statin can easily induce liver injury and myopathy. Low-density lipoprotein cholesterol (LDL-C) is a well-established modifiable risk factor for cardiovascular disease; however, the large majority of Chinese patients cannot me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jing, Liu, Jing-Yu, Lu, Peng-Ju, Xiao, Jian-Yong, Gao, Ming-Dong, Li, Chang-Ping, Cui, Zhuang, Liu, Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650150/ https://www.ncbi.nlm.nih.gov/pubmed/34887772 http://dx.doi.org/10.3389/fphys.2021.750872

Ejemplares similares

Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Effects of Evolocumab on Carotid Intima-Media Thickness and Clinical Parameters in Patients Taking a Statin
por: Hirai, Keiji, et al.
Publicado: (2020)

What Is Moderate to Vigorous Exercise Intensity?
por: MacIntosh, Brian R., et al.
Publicado: (2021)

Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial
por: Koba, Shinji, et al.
Publicado: (2020)

Effects of Evolocumab on Cardiovascular Events
por: Mikhail, Nasser
Publicado: (2017)

The Effect of Moderate-Intensity Treadmill Exercise on Bone Mass and the Transcription of Peripheral Blood Mononuclear Cells in Ovariectomized Rats
por: Gao, Li, et al.
Publicado: (2021)

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
por: Huang, Chin-Chou, et al.
Publicado: (2019)

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial
por: Chen, Yundai, et al.
Publicado: (2019)

Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study
por: Chai, Meng, et al.
Publicado: (2023)

Effect of Evolocumab on Vulnerable Coronary Plaques: A Serial Coronary Computed Tomography Angiography Study
por: Hirai, Keiji, et al.
Publicado: (2020)

Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial
por: Na, Hye Rim, et al.
Publicado: (2022)

Commentary: High-intensity Intermittent Training vs. Moderate-intensity Intermittent Training: Is It a Matter of Intensity or Intermittent Efforts?
por: Gentil, Paulo, et al.
Publicado: (2017)

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial
por: Lorenzatti, Alberto J., et al.
Publicado: (2019)

Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
por: Li, Zhenxian, et al.
Publicado: (2023)

Response: Commentary: High-intensity Intermittent Training vs. Moderate-intensity Intermittent Training: Is It a Matter of Intensity or Intermittent Efforts?
por: Jiménez-Pavón, David, et al.
Publicado: (2017)

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Cerebrovascular Function in the Large Arteries Is Maintained Following Moderate Intensity Exercise
por: Steventon, Jessica J., et al.
Publicado: (2018)

Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
por: Cerqueira, Érica, et al.
Publicado: (2020)

Regression and Stabilization of Coronary Vulnerable Plaque by Evolocumab as Assessed by Multidetector Row Computed Tomography
por: Shiga, Yuhei, et al.
Publicado: (2020)

Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease
por: Choi, Seung Woo, et al.
Publicado: (2022)

Comparative Effectiveness of High-Intensity Interval Training and Moderate-Intensity Continuous Training for Cardiometabolic Risk Factors and Cardiorespiratory Fitness in Childhood Obesity: A Meta-Analysis of Randomized Controlled Trials
por: Liu, Jingxin, et al.
Publicado: (2020)

Profile of evolocumab and its potential in the treatment of hyperlipidemia
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Maculopapular Exanthema After the Second Dose of Evolocumab
por: Ghernautan, Victoria, et al.
Publicado: (2021)

Evolocumab enables rapid LDL-C reduction and inflammatory modulation during in-hospital stage of acute coronary syndrome: A pilot study on Chinese patients
por: Ou, Ziwei, et al.
Publicado: (2022)

Six Weeks of Polarized Versus Moderate Intensity Distribution: A Pilot Intervention Study
por: Röhrken, Golo, et al.
Publicado: (2020)

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
por: Kim, Byung Gyu, et al.
Publicado: (2023)

Effects of High-Intensity Interval and Moderate-Intensity Continuous Exercise on Inflammatory, Leptin, IgA, and Lipid Peroxidation Responses in Obese Males
por: de Souza, Daniel C., et al.
Publicado: (2018)

The Effects of Concurrent Training Combining Both Resistance Exercise and High-Intensity Interval Training or Moderate-Intensity Continuous Training on Metabolic Syndrome
por: Da Silva, Marco Antônio R., et al.
Publicado: (2020)

Activation of TRPV4 by lactate as a critical mediator of renal fibrosis in spontaneously hypertensive rats after moderate- and high-intensity exercise
por: Zhao, Binyi, et al.
Publicado: (2022)

Impact of 12-Week Moderate-Intensity Aerobic Training on Inflammasome Complex Activation in Elderly Women
por: Gomarasca, Marta, et al.
Publicado: (2022)

Short-Term High- and Moderate-Intensity Training Modifies Inflammatory and Metabolic Factors in Response to Acute Exercise
por: Lira, Fabio Santos, et al.
Publicado: (2017)

Examination of the Myokine Response in Pregnant and Non-pregnant Women Following an Acute Bout of Moderate-Intensity Walking
por: Hutchinson, Kelly Ann, et al.
Publicado: (2019)

An Estimate of Plasma Volume Changes Following Moderate-High Intensity Running and Cycling Exercise and Adrenaline Infusion
por: Bjerre-Bastos, Jonathan J., et al.
Publicado: (2022)

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
por: Blom, Dirk J, et al.
Publicado: (2016)

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety
por: Lee, Edward, et al.
Publicado: (2019)

Atrial Fibrillation as a Possible Adverse Reaction to Evolocumab
por: Abdelmaseih, Ramy, et al.
Publicado: (2021)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease
por: Li, Jia-Lin, et al.
Publicado: (2023)

Low cadence interval training at moderate intensity does not improve cycling performance in highly trained veteran cyclists
por: Kristoffersen, Morten, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q90iiobbojg1pnudg834ivh9od